Madrigal Pharmaceuticals (MIL:1MDGL) Total Liabilities: €591.6 Mil (As of Mar. 2026)


MIL:1MDGL Madrigal Pharmaceuticals Inc MIL:1MDGL
8 GF Score
Price €460.60
! 4 Warning Signs
View Full Analysis

What is Madrigal Pharmaceuticals Total Liabilities?

Madrigal Pharmaceuticals MIL:1MDGL 8 Total Liabilities is €591.6 Mil as of Mar. 2026. GuruFocus rates MIL:1MDGL with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Madrigal Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 was €591.6 Mil.

Madrigal Pharmaceuticals's quarterly Total Liabilities declined from Sep. 2025 (€627.69 Mil) to Dec. 2025 (€560.99 Mil) but then increased from Dec. 2025 (€560.99 Mil) to Mar. 2026 (€591.55 Mil).

Madrigal Pharmaceuticals's annual Total Liabilities increased from Dec. 2023 (€215.69 Mil) to Dec. 2024 (€274.91 Mil) and increased from Dec. 2024 (€274.91 Mil) to Dec. 2025 (€560.99 Mil).

Madrigal Pharmaceuticals Total Liabilities Historical Data

* Premium members only.

The historical data trend for Madrigal Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Madrigal Pharmaceuticals Total Liabilities Chart

Madrigal Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.34 155.93 215.69 274.91 560.99

Madrigal Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 264.54 276.92 627.69 560.99 591.55
MIL:1MDGL
8GF Score
Madrigal Pharmaceuticals Inc MIL:1MDGL
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Madrigal Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Madrigal Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=264.986+(296.007+5.6843418860808E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=561.0

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1075.689-514.696
=561.0

Madrigal Pharmaceuticals's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=292.594+(298.956+-5.6843418860808E-14
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=591.6

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1061.638-470.088
=591.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €591.6 Mil mean?
Madrigal Pharmaceuticals (MIL:1MDGL) has a Total Liabilities of €591.6 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Madrigal Pharmaceuticals and its competitors.
Is Madrigal Pharmaceuticals' Total Liabilities too high?
Madrigal Pharmaceuticals' current Total Liabilities is €591.6 Mil. Overall, Madrigal Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Madrigal Pharmaceuticals' Total Liabilities compare to BMRN and AXSM?
Madrigal Pharmaceuticals' Total Liabilities of €591.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Madrigal Pharmaceuticals and its competitors. Madrigal Pharmaceuticals's current Total Liabilities is €591.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Madrigal Pharmaceuticals stock overvalued right now?
Madrigal Pharmaceuticals (MIL:1MDGL) has a current Total Liabilities of €591.6 Mil. The current Total Liabilities is €591.6 Mil. Madrigal Pharmaceuticals' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Madrigal Pharmaceuticals (MIL:1MDGL), the current Total Liabilities is €591.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Madrigal Pharmaceuticals Business Description

Other Exchanges MDGL:USA0JXI:UKYDO1:Germany
Address 200 Barr Harbor Drive, Suite 200, Four Tower Bridge, West Conshohocken, PA, USA, 19428
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
8GF Score

Get the complete analysis for MIL:1MDGL

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€460.60
Price